The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Behavioural Brain Research

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/0166-4328(95)00213-8PMID 8793035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subtypes and differential laminar distributions of βA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases

  2004cited by this paper
• Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients

  1995cited by this paper
• [Premorbid psychological processes in patients with Alzheimer's disease and in patients with vascular dementia].

  1995cited by this paper
• Inflammation as a pathogenic mechanism in Alzheimer's disease.

  1995cited by this paper
• Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain--implications for neuronal plasticity.

  1994cited by this paper
• Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP).

  1994cited by this paper
• Analysis of staining methods for different cortical plaques in Alzheimer's disease

  1994cited by this paper
• Glutamate, learning and dementia-selection of evidence

  1994cited by this paper
• Interleukin-6 and selected plasma proteins in healthy persons of different ages.

  1994cited by this paper
• Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

  1994cited by this paper
• Induction of plasma interleukin-6 by circulating adrenaline in the rat.

  1994cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cited by this paper
• Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha.

  1993cited by this paper
• Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

  1993cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  1993cited by this paper
• Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

  1993cited by this paper
• Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis.

  1993cited by this paper
• Interleukin‐6: A Cytokine for Gerontolgists

  1993cited by this paper
• Temporal Sequence of Plaque Formation in the Cerebral Cortex of Non-Demented Individuals

  1993cited by this paper
• An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET.

  1993cited by this paper
• Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

  1993cited by this paper
• Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide.

  1993cited by this paper
• Microglia in degenerative neurological disease

  1993cited by this paper
• Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα

  1993cited by this paper
• Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine.

  1993cited by this paper
• Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.

  1992cited by this paper
• Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.

  1991cited by this paper
• Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

  1991cited by this paper
• Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

  1990cited by this paper
• The effects of psychological stress on plasma interleukin-6 activity in rats.

  1990cited by this paper
• Book reviewEnriched and impoverished environments: Effects on brain and behavior: By M.J. Renner and M.R. Rosenzweig, Springer-Verlag, 1988

  1990cited by this paper
• Die Alzheimer-Krankheit

  1989cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• A COMPARATIVE STUDY OF MODIFIED BIELSCHOWSKY, BODIAN AND THIOFLAVIN S STAINS ON ALZHEIMER'S NEUROFIBRILLARY TANGLES

  1986cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper

• Chronic central-targeted Interleukin-6 overexpression promotes hippocampal and cortical neuropathology in the Tg2576 mouse model of Alzheimer’s disease

  2026cites this paper
• Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

  2023cites this paper
• APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-κB activation.

  2022cites this paper
• p38 MAPK Is a Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia

  2022cites this paper
• SARS-Cov2-Induced Cytokine Storm and Schizophrenia, Could There be a Connection?

  2022cites this paper
• Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults

  2022cites this paper
• Role of IL-6 in the regulation of neuronal development, survival and function.

  2021cites this paper
• Probing gut‐brain links in Alzheimer's disease with rifaximin

  2021cites this paper
• New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo.

  2020cites this paper
• β-Catenin and TCFs/LEF signaling discordantly regulate IL-6 expression in astrocytes

  2020cites this paper
• Compilação sobre possíveis biomarcadores para doença de Alzheimer

  2020cites this paper
• Astrocytes and Inflammatory Processes in Alzheimer’s Disease

  2020cites this paper
• Context dependent cytokine secretion by stem cell derived microglia in vitro

  2020cites this paper
• Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer's disease neuroimaging initiative database.

  2020cites this paper
• Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.

  2019cites this paper
• IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer's disease.

  2019cites this paper
• The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies

  2019cites this paper
• Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage.

  2019cites this paper
• Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.

  2019cites this paper
• Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

  2018cites this paper
• Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention

  2018influential citation
• Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway

  2018cites this paper
• Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer’s Disease: Testosterone as a Modifier

  2017cites this paper
• Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease

  2017cites this paper
• Sugar-sweetened soft drinks are associated with poorer cognitive function in individuals with type 2 diabetes: the Maine-Syracuse Longitudinal Study.

  2016cites this paper
• TLR2/NFκB signalling regulates endogenous IL-6 release from marrow-derived mesenchymal stromal cells to suppress the apoptosis of PC12 cells injured by oxygen and glucose deprivation.

  2016cites this paper
• Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.

  2016cites this paper
• Association study of the BIN1 and IL-6 genes on Alzheimer's disease.

  2016cites this paper
• Type 2 Diabetes Mellitus and Alzheimer's Disease: Bridging the Pathophysiology and Management.

  2016cites this paper
• Recent Updates on the Association Between Alzheimer's Disease and Vascular Dementia.

  2016cites this paper
• Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-δ-dependent caspase signaling pathway: in vivo and in vitro studies.

  2016cites this paper
• Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats.

  2016cites this paper
• EVALUATION OF MELATONIN, AND ADIPOKINES IN PATIENTS WITH ALZHEIMER’S DISEASE

  2015cites this paper
• Inflammatory Mediators and the Blood-Brain Barrier

  2015cites this paper
• Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study

  2015cites this paper
• Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients

  2015cites this paper
• Inflammatory response in heroin addicts undergoing methadone maintenance treatment.

  2015cites this paper
• Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease

  2014cites this paper
• Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies.

  2014cites this paper
• Role of astrocytic IL-6 and IL-6R in normal physiology and neuroinflammation

  2014cites this paper
• Central Adiposity & the Functional Magnetic Resonance Imaging Response to Cognitive Challenge

  2014cites this paper
• Mechanisms of Action of Phytochemicals from Medicinal Herbs in the Treatment of Alzheimerʼs Disease

  2014cites this paper
• Association Between Interleukin 6 Gene Haplotype and Alzheimer's Disease: A Brazilian Case-Control Study

  2013cites this paper
• Inflammation, neurotoxins and psychiatric disorders.

  2013cites this paper
• Berberine suppresses amyloid‐beta‐induced inflammatory response in microglia by inhibiting nuclear factor‐kappaB and mitogen‐activated protein kinase signalling pathways

  2012cites this paper
• Cerebrovascular Disorders: Role of Aging

  2012cites this paper
• Interleukin-6, a Major Cytokine in the Central Nervous System

  2012cites this paper
• Insulin and Alzheimer's Disease: Untangling the Web

  2012cites this paper
• Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

  2012cites this paper
• Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

  2011cites this paper
• Cytokines and memory across the mature life span of women.

  2011cites this paper
• Has dysregulated interleukin-6 gene a role in the development of Alzheimer's disease?

  2011cites this paper
• Neurobiology of Vascular Dementia

  2011cites this paper
• Interleukin-6, a mental cytokine.

  2011influential citation
• Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

  2010cites this paper
• Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.

  2009cites this paper
• Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.

  2009cites this paper
• The expression of inflammatory genes in human brain endothelial cells stimulated by beta-amyloid peptides is mediated by JNK-AP1 signaling pathway

  2008cites this paper
• Association between genetic variants of IL-1β, IL-6 and TNF-α cytokines and cognitive performance in the elderly general population of the MEMO-study

  2008cites this paper
• Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage.

  2008cites this paper
• Progress in Neurotherapeutics and Neuropsychopharmacology: Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment

  2008cites this paper
• Cognitive dysfunction and diabetes mellitus.

  2008cites this paper
• Cognitive impairment and diabetes.

  2008cites this paper
• Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study.

  2008cites this paper
• The TNF-α-238G > A single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes

  2007cites this paper
• The TNF-alpha-238G > a single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes.

  2007cites this paper
• Obesity and dementia: lifecourse evidence and mechanisms

  2006cites this paper
• Frontotemporal dementia--a brief review.

  2006cites this paper
• Inflammatory cytokines and NFκB in Alzheimer’s disease.

  2006cites this paper
• Induction of IL-6 expression by mechanical stress in the trabecular meshwork.

  2005cites this paper
• The influence of advanced age on cancer occurrence and growth.

  2005cites this paper
• Expressions of cytokines and chemokines in the dorsal motor nucleus of the vagus nerve after right vagotomy.

  2005cites this paper
• beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells.

  2005cites this paper
• Effects of neutralising interleukin-6 on glucocorticoid-mediated adaptations to stress in rat skeletal muscle and liver

  2005cites this paper
• Cognitive function in young and adult IL (interleukin)-6 deficient mice.

  2004cites this paper
• THE HERBAL PRESCRIPTION YOUKONGDAN MODULATES RODENT MEMORY, ISCHEMIC DAMAGE AND CORTICAL mRNA GENE EXPRESSION

  2004cites this paper
• Aging biology and cancer.

  2004cites this paper
• Characterization of V642I‐AβPP‐induced cytotoxicity in primary neurons

  2004cites this paper
• Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications

  2004cites this paper
• Retardation of Brain Aging by Chronic Treatment with Melatonin

  2004cites this paper
• Experimental herpes simplex virus encephalitis: a long-term study of interleukin-6 expression in mouse brain tissue.

  2004cites this paper
• Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

  2004cites this paper
• Canine counterpart of senile dementia of the Alzheimer type: amyloid plaques near capillaries but lack of spatial relationship with activated microglia and macrophages

  2003cites this paper
• The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease

  2003cites this paper
• Cytokines in degenerative brain diseases: lessons from transgenic animals.

  2002cites this paper
• Effects of acute psychological stress on adhesion molecules, interleukins and sex hormones: implications for coronary heart disease

  2002influential citation
• TH1/TH2 CYTOKINES IN THE CENTRAL NERVOUS SYSTEM

  2002cites this paper
• The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.

  2002cites this paper
• NEL R E VIEW - H AR V A RD R E POR T The role of stress in neurodegenerative diseases and mental disorders

  2002influential citation
• The role of stress in neurodegenerative diseases and mental disorders.

  2002cites this paper
• Dietary melatonin selectively reverses age-related changes in cortical cytokine mRNA levels, and their responses to an inflammatory stimulus.

  2002cites this paper
• Cellular and molecular mechanisms of Alzheimer’s disease inflammation

  2001cites this paper
• Cerebrospinal fluid contains biologically active bone morphogenetic protein-7.

  2001cites this paper
• Molecular and cellular mediators of Alzheimer's disease inflammation

  2001cites this paper
• Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.

  2001cites this paper
• Effects of Intrahippocampal Infusion of lnterleukin-6 on Passive Avoidance and Nitrite and Prostaglandin Levels in the Hippocampus in Rats

  2000cites this paper
• Neurotoxic Effects of lnterleukin-6 and Sodium Nitroprusside on Cultured Rat Hippocampal Neurons

  2000cites this paper
• Does the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration?

  2000cites this paper
• Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

  2000cites this paper
• Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in N1E-115 neuroblastoma cells.

  2000cites this paper